# RYLAZE
> **BLA761179** · Biologics License Application · Sponsor: JAZZ PHARMS · Approved 2021-06-30
## Drug
- **FDA Application Number:** BLA761179
- **Application type:** Biologics License Application
- **Brand name:** RYLAZE
- **Generic name:** ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN
- **Active ingredients:** ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN
- **Dosage form:** INJECTABLE
- **Route:** INTRAMUSCULAR
- **Marketing status:** Prescription
- **Sponsor:** JAZZ PHARMS
- **Manufacturer:** Jazz Pharmaceuticals, Inc.
- **First approval:** 2021-06-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761179)
---
*MORVS · CC0 1.0*